A photo provided by the Centers for Disease Control and Prevention of cultured Candida auris in a petri dish.
“Seeing the world as a one-pathogen world is really problematic,” said Dr. Susan S. Huang, an infectious disease specialist at the University of California at Irvine Medical School, noting that the nearly singular focus on the pandemic appears to have led to more spread of drug-resistant infection. “We have every reason to believe the problem has gotten worse.”
Noxious drug-resistant bacteria are surfacing too, including Carbapenem-resistant Acinetobacter baumannii, which is considered an “urgent health threat” by the Centers for Disease Control and Prevention. In December, the CDC reported a cluster of Acinetobacter baumannii during a surge of COVID-19 patients in an urban New Jersey hospital with about 500 beds. The hospital was not identified. And hospitals in Italy and Peru saw the spread of the bacteria Klebsiella pneumoniae.
Huang and other experts said they are not suggesting that the priority on fighting COVID-19 was misplaced. Rather, they say that renewed attention must be paid to drug-resistant germs. Earlier research has shown that as many as 65% of residents of nursing homes carry some form of drug-resistant infection.